The Safety and Effectiveness of Decapeptide in Patients With Vitiligo: A Real-World Study

Background Vitiligo, a chronic autoimmune depigmenting skin disease, affects a significant portion of the global population. One of the topical treatment options for vitiligo is basic fibroblast growth factor (bFGF)-related decapeptide (bFGFrP) 0.1% solution. This study aimed to assess the real-worl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Aseem, Majid, Imran, Kumar, Hari K, Banodkar, Pravin, Mhatre, Madhulika, Mohod, Bhagyashree, Jaiswal, Ashok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403243/
https://www.ncbi.nlm.nih.gov/pubmed/37546028
http://dx.doi.org/10.7759/cureus.41418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403243/
https://www.ncbi.nlm.nih.gov/pubmed/37546028
http://dx.doi.org/10.7759/cureus.41418

Ejemplares similares